Polygen Pharmaceuticals

Polygen Pharmaceuticals is a privately held specialty pharmaceutical company headquartered in Edgewater, New Jersey. The company focuses on the development and commercialization of generic prescription products for the United States healthcare market. Polygen's portfolio primarily consists of small molecule therapeutics delivered in oral solid dosage forms, targeting therapeutic areas such as neurology, endocrinology, and psychiatry. The firm utilizes a lean business model, often collaborating with global manufacturing partners to bring cost-effective generic alternatives to market. Their product line includes several FDA-approved Abbreviated New Drug Applications (ANDAs) for widely used medications.